INTRODUCTION
Defect were classified as moderate if the upper quadrant were affected, whereas in combined upper and lower quadrant field defect was classified as severe. Visual assessment was repeated three months after surgery. Recordings were done for both eyes separately. Study was done for a period of one year from March 2018 to April 2019. Patients' demographic data, visual assessment, size of tumor in MRI, Completeness of surgical resection were documented. Study proposal was approved and supervised by Institution Research Board of NAMS. Sample size of twenty eight eyes was taken. Statistical analyses was performed using the SPSS 23.0 software (SPSS, Inc., Chicago, IL, USA). Descriptive statistics of ratio scaled variables were expressed as mean ± standard deviation (SD). Relationships between visual improvement and other ordinal data was studied by spearman rho test. Binomial variables will be tested using Chi-square. Visual acuity and field before and after surgery was evaluated using paired t-test. Values of P < 0.05 will be considered statistically significant.
RESULTS
Fourteen patients who had visual impairment and underwent surgery for excision of pituitary tumor were analysed. Out of fourteen patients, six (43%) were female. Mean age at presentation was 38.86±12.68 (16-66) years. Headache was most common nonvisual symptom followed by amenorrhea and acromegaly. Mean duration of visual alteration was 13.71±10.83 (1-36) months ( Table 1) . Fundoscopy revealed temporal paleness in ten (35%), papilledema in six (21%), optic atrophy in five (18%) and normal in seven (25%) eyes ( Figure 1 ). Nonfunctioning pituitary adenoma (50%) was most common tumor followed by prolactinomas (29%) and acromegaly (21%). Average size of tumor was 3.07±1.1 (1.5-5.0) cms. Thirteen (92%) patients had endonasal transsphenoidal approach while three (22%) patients underwent transcranial resection. Two had a second stage transcranial surgery. Tumor resection was complete in eleven (78.57%) patients. Visual acuity was stratified as per WHO classification of visual impairment. Visual acuity at presentation and after 3 months is depicted in (Figure 1 ).
Four eyes had normal visual acuity, six grade I, nine Grade II visual impairment. Visual acuity improvement was marked in Group III. Visual acuity improvement was seen in seventeen (60%) eyes. The mean of improvement of visual acuity in preoperative and postoperative study was statistically significant (p-value=0.047, CI 95% =0.039-0.639). Visual field was semi quantitatively stratified into mild, moderate and severe deficit. Visual field in preoperative and postoperative subjects was as depicted in ( Improvement of visual field was statistically associated with size of tumor at presentation (p-value=0.028). However association with duration of symptom (p-value=0.98), presence of optic atrophy (p-value=0.112), improvement in visual acuity (p-value=0.83), completeness of excision (p-value=0.25), size of tumor (p-value=0.12) was not statistically significant. Imaging and perimetry of a case who had improvement in both visual field and acuity following surgery is shown in (Figure 4 ).
DISCUSSION
Visual impairment is a common presentation of pituitary tumor. Prediction of visual outcome after surgery is a key concern for management of pituitary tumor. Various studies [6] [7] [8] [9] [10] [11] have heterogeneous results on visual outcome following surgery. Majority of Studies were retrospective. Surgical excision is the treatment of choice in pituitary adenoma with significant mass effect. Pituitary adenoma is disease of young adults. Mean age of patients in our study was 38.86 yrs. This is lower compared to similar studies. 4, 6, 12 Like other studies, 12 majority of patients in our series were female. Duration of symptom before presentation was longer (13 months) than previous studies. 6, 12, 13 Mean size of tumor was larger in (3.07 cms) in our study. Nonfunctioning tumors were most common.
Our study showed less recovery of visual field in patients with bigger tumors. This is in coherence with other studies. 6, 14 Larger tumors need to be prioritized for surgery. Optic atrophy was present in 18% in our series which was comparable to other studies (7-30%). 6, 7, 13 These patients had poor improvement of both visual acuity and field of vision. Mean duration of visual loss in our patients was 13.71 months. This is higher than previous studies. 7, 12 Longer duration tumors tend to have bad visual outcome. 6, 13, 15 Complete excision at times is not safe due to potential risk to vital vascular structures, extension to extra sellar space. Choice of route of approach to sella could be trans-sphenoidal or cranial. Gross resection was achieved in 11 (78%) patients in our series. However there was no significant association between completeness of resection and improvement of visual field defect. This is similar to prior studies by Gnanalingham 6 and Musluman. 7 Two patients needed two stage surgery from different routes. We used WHO grading of visual impairment of distant vision to categorize Visual acuity. Other studies use snellen's chart lines to quantify visual acuity. We have used semi quantitative measures of classification of visual field defect. Our study showed preoperative Visual Acuity, Visual field, improvement of Visual acuity and size of tumor to be significantly associated with visual field improvement. Improvement of visual acuity at three months was 51% in our series. 
CONCLUSIONS

